BioPharm

JANUARY 19, 2024

In silico process development for chromatography is a paradigm-shifting approach that redefines the routine work of process development scientists. But what does it actually mean to perform process development in silico? Do I need to be a math expert? Where is modeling applicable?

52

52

pharmaphorum

JANUARY 18, 2024

Viral Vector Process Development & Manufacturing Summit Returns to Boston! Mike.Hammerton Thu, 18/01/2024 - 21:36 Bookmark this

52

52

pharmaphorum

DECEMBER 8, 2023

2nd mRNA Process Development & Manufacturing Summit Europe Mike.Hammerton Fri, 08/12/2023 - 14:08 Bookmark this

52

52

pharmaphorum

MAY 9, 2023

2nd mRNA Process Development & Manufacturing Summit Mike.Hammerton Tue, 05/09/2023 - 09:49 Bookmark this

52

52

pharmaphorum

JUNE 2, 2023

2nd Process Development for Cell Therapies Mike.Hammerton Fri, 06/02/2023 - 10:15 Bookmark this

52

52

Outsourcing Pharma

DECEMBER 15, 2022

Avid Bioservices has raised its full-year revenue guidance after process development sales hit a new high in its latest quarterly financial results.

52

52

BioPharm

NOVEMBER 1, 2022

Increasing molecular diversity is creating a need for the reinvention of process development and control strategies.

59

59

pharmaphorum

JANUARY 27, 2022

Embrace Technology Innovations to Optimise LNP Formulation, Alternative LNP Raw Materials, Process Control to Achieve Seamless Scale-Up, Compliance & Cost Effectiveness . With the overwhelming possibilities of lipid nanoparticles, there are key questions on formulation, process development and scalability that still need to be answered.

Vaccines 52

Vaccines 52

PQA

FEBRUARY 23, 2023

In the year ahead, PQA will continue developing innovative measure approaches for high-impact areas of care. The pinnacle of PQA’s measure development process is the membership endorsement vote. We will also convene members this year to support the measure development process.

Specialty Pharmacies 40

Specialty Pharmacies Documentation Communication 40

pharmaphorum

OCTOBER 19, 2023

Innovative biopharma including BioNTech, Genentech, AskBio, Pfizer, Roche, Sanofi and more will unite in Boston

52

52

Pharmafile

JANUARY 27, 2023

UK-based pharmaceutical drug discovery company IsoChemiX is developing molecules which will have the ability to cut both the time and cost of bringing a new drug to market. IsoChemiX say its product will make the process faster by six months and reduce the overall cost by up to £87m. read more

40

40

pharmaphorum

JULY 1, 2021

The clinical trial process is a long, expensive, complicated one that often ends in failure. This allows the FDA to receive, process, review and archive submissions efficiently. As part of a collaboration with the FDA, CDISC developed data standards to be used from study design and data collection through to analysis.

FDA 58

FDA Communication 58

Pharma Tutor

JULY 13, 2022

A REVIEW ON COMPUTER AIDED DRUG DESIGN (CAAD) AND IT’S IMPLICATIONS IN DRUG DISCOVERY AND DEVELOPMENT PROCESS. Read more about A REVIEW ON COMPUTER AIDED DRUG DESIGN (CAAD) AND IT’S IMPLICATIONS IN DRUG DISCOVERY AND DEVELOPMENT PROCESS Log in or register to post comments About Authors. Sayyed , Ms. Review Articles.

59

59

BioPharm

MARCH 21, 2023

Sartorius BIA Separations and Teknova will collaborate to combine their technologies in an effort to streamline the downstream purification process.

98

98

BioPharm

SEPTEMBER 21, 2022

Wed, Sep 21, 2022 2:00 PM EDT This webinar will review the key considerations and gaps in evaluating freeze/thaw solutions, examine the elements of a dedicated technology center to bridging these gaps and development risks, and explore successful case studies of a technology center optimizing processes and speed-to-market.

40

40

BioPharm

MARCH 24, 2024

Webinar Date/Time: Thu, Thu, Apr 18, 2024 11:00 AM EDT

52

52

Pharma Times

JUNE 9, 2022

Agreement between the two companies includes process development of AAV-based gene therapies

40

40

BioPharm

JANUARY 31, 2024

The authors present a methodology to assess the contribution of individual filters to overall capacity of the direct filtration train, and elucidate how capacity is affected by characteristics of the cell culture broth and process parameters, including for enhanced upstream processes such as those incorporating high cell density perfusion.

52

52

BioPharm

MARCH 1, 2024

The authors evaluated the potential of direct filtration for multiple biopharmaceutical candidates. This article is Part 2 of the study.

52

52

PhRMA

JUNE 15, 2023

America’s biopharmaceutical research companies are central to the research and development (R&D) of innovative medicines in the United States. Unfortunately, a new report by Sen.

202

202

pharmaphorum

APRIL 26, 2024

Chemists at ETH Zurich have developed a new computer process that enables the generation of active pharmaceutical ingredients at speed, based on a protein’s three-dimensional surface.

97

97

BioPharm

SEPTEMBER 15, 2023

AI’s role in target discovery and manufacturing optimization remained the most chosen application looking three years ahead; however, approximately 43% envision that it will help to build base regulatory submissions.

52

52

Pharmaceutical Commerce

MARCH 10, 2023

Project addresses customer demand in GMP-powered advanced therapeutics.

52

52

PhRMA

DECEMBER 1, 2022

Each day, in labs across the country, these individuals work tirelessly on the front lines of research and development to help bring novel medicines to patients. More often than not, the process of researching and developing innovative treatments is fraught with more setbacks than successes. This challenge is far from easy.

264

264

BioPharm

JULY 23, 2023

Webinar Date/Time: Tue, Aug 15, 2023 11:00 AM EDT

52

52

pharmaphorum

FEBRUARY 21, 2024

Clinical research involves trial and error as part of the drug development process. Learn more about how to optimise drug trials and the important role of participants in clinical research.

124

124

Pharmacy Times

MARCH 29, 2024

The mutations, C594Y and P735R, were found in the GNE gene and may influence sialylation, a process that is crucial for brain development.

107

107

pharmaphorum

FEBRUARY 14, 2024

Discover how artificial intelligence (AI) is revolutionising the drug development process and transforming the way FDA-approved drugs are produced, ensuring compliance and optimising the supply chain. Learn more about the future of AI in pharmaceuticals.

FDA 127

FDA 127

European Pharmaceutical Review

SEPTEMBER 12, 2023

As part of The Future of Pharma/Biopharma Analysis 2023 , which took place on 28-29 June 2023, European Pharmaceutical Review ( EPR ) gathered an expert panel to discuss developing a modern contamination control strategy. Next, a data-driven approach and scientific principles must be used, along with validated methods and processes.

Documentation 124

Documentation 124

STAT

MARCH 20, 2024

Scientists at the University of Wisconsin-Madison have spent years trying to unravel the details of Down syndrome: What happens inside the womb, how the genetic disorder alters the formation of neurons, and what specific processes affect brain development. The work can’t proceed without studying fetal tissue.

129

129

pharmaphorum

JANUARY 10, 2024

Learn more about their innovative vaccine development process and their commitment to creating a healthier future. Novavax is a leading pharmaceutical company dedicated to creating protein-based vaccines for diseases like COVID-19 and malaria.

Vaccines 123

Vaccines Pharmaceutical Companies Pharmaceutical Companies 123

STAT

APRIL 1, 2024

Called Rejoyn , the smartphone-based treatment for major depressive disorder symptoms, developed with digital health company Click Therapeutics, is intended for use by prescription alongside antidepressants. ” Patients also receive cognitive behavioral therapy.

FDA 139

FDA Insurance 139

European Pharmaceutical Review

APRIL 11, 2024

Because there are so many biosimilars in various stages of development, the report predicted that expansion of the biologics market will likely “slow down soon”. The author wrote that biosimilar products allow companies to reduce their spending on the development and commercial side.

94

94

STAT

MARCH 8, 2024

People experiencing mental health conditions are prescribed various drugs until one (or a combination) finally works — a painful process that can take years. Despite significant efforts, progress in psychiatric drug development has remained disappointingly slow. In many ways, psychiatry is still flying blind.

103

103

European Pharmaceutical Review

MARCH 1, 2024

million investment is set to support the development of innovative solutions to drive advancements in sustainable biomanufacturing in the UK. The UK Research and Innovation ( UKRI ) is backing 21 cross-sector collaborations designed to generate innovation, commercialisation and growth in this area.

Packaging 75

Packaging 75

pharmaphorum

JANUARY 12, 2024

AI technology is revolutionising the field of clinical trials by enhancing patient identification, accelerating drug development and design, and improving monitoring processes. Discover how AI is supercharging clinical trials for better healthcare outcomes.

105

105

Pharmaceutical Technology

JANUARY 21, 2024

CDMOs, who cater to the requirements of multiple companies and develop platform processes to achieve the much-needed economy of scale, are being seen as a possible solution.

98

98